A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride

被引:0
|
作者
Karayagmurlu, Ali [1 ]
Karayagmurlu, Elif [2 ]
Ustundag, Mehmet Fatih [3 ]
Yazla, Ece [4 ]
机构
[1] Gaziantep Child State Hosp, Dept Child & Adolescent Psychiat, Gaziantep, Turkey
[2] Gaziantep Univ, Dept Psychiat, Fac Med, Gaziantep, Turkey
[3] Erenkoy Training & Res Hosp Psychiat & Neurol Dis, Dept Psychiat, Istanbul, Turkey
[4] Hitit Univ, Fac Med, Dept Psychiat, Corum, Turkey
来源
ELECTRONIC JOURNAL OF GENERAL MEDICINE | 2018年 / 15卷 / 03期
关键词
amisulpride; atypical antipsychotics; neuroleptic malignant syndrome; electroconvulsive therapy;
D O I
10.29333/ejgm/83617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Neuroleptic malignant syndrome
    Moscovich, Mariana
    Novak, Felipe T. M.
    Fernandes, Artur F.
    Bruch, Tatiana
    Tomelin, Tabita
    Novak, Edison M.
    Munhoz, Renato P.
    Teive, Helio A. G.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2011, 69 (05) : 751 - 755
  • [32] Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride
    Angelopoulos, Petros
    Markopoulou, Maria
    Kyamidis, Kyriakos
    Bobotas, Konstantinos
    GENERAL HOSPITAL PSYCHIATRY, 2008, 30 (05) : 482 - 484
  • [33] Successful treatment of a complicated case of neuroleptic malignant syndrome
    Lappa, A
    Podestà, M
    Capelli, O
    Castagna, A
    Di Placido, G
    Alampi, D
    Semeraro, F
    INTENSIVE CARE MEDICINE, 2002, 28 (07) : 976 - 977
  • [34] SAFETY OF THE ELECTROCONVULSIVE THERAPY AND AMISULPRIDE COMBINATION
    Takacs, Rozalia
    Ivanyi, Zsolt
    Ungvari, Gabor S.
    Gazdag, Gabor
    PSYCHIATRIA DANUBINA, 2013, 25 (01) : 76 - 79
  • [35] Serotonin syndrome vs neuroleptic malignant syndrome: A contrast of causes, diagnoses, and management
    Perry, Paul J.
    Wilborn, Courtney A.
    ANNALS OF CLINICAL PSYCHIATRY, 2012, 24 (02) : 155 - 162
  • [36] Aripiprazole and neuroleptic malignant syndrome
    Chakraborty, N
    Johnston, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (06) : 351 - 353
  • [37] Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
    Mann, Stephan C.
    Caroff, Stanley N.
    Ungvari, Gabor S.
    Campbell, E. Cabrina
    CURRENT PSYCHIATRY REVIEWS, 2013, 9 (02) : 111 - 119
  • [38] Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus
    Arslankoylu, Ali Ertug
    Kutuk, Meryem Ozlem
    Okuyaz, Cetin
    Toros, Fevziye
    PEDIATRIC REPORTS, 2011, 3 (03) : 81 - 82
  • [39] Neuroleptic malignant syndrome due to three atypical antipsychotics in a child
    Chung, DS
    Kim, BN
    Cho, SC
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (04) : 422 - 425
  • [40] Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal
    Young, CC
    Kaufman, BS
    JOURNAL OF CLINICAL ANESTHESIA, 1995, 7 (08) : 652 - 656